Yale Jen
Stock Analyst at Laidlaw & Co.
(0.05)
# 4,064
Out of 4,814 analysts
15
Total ratings
14.29%
Success rate
-46.26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICAD iCAD, Inc. | Downgrades: Hold | n/a | $3.05 | - | 1 | Apr 17, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $69.21 | +51.71% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $8.48 | +124.06% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $10 | $1.41 | +609.22% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $6.34 | +657.10% | 1 | Jul 29, 2024 | |
| MEIP MEI Pharma | Downgrades: Hold | n/a | $1.91 | - | 1 | Jul 23, 2024 | |
| AFMD Affimed | Maintains: Buy | $15 → $25 | $0.72 | +3,393.08% | 1 | Jun 13, 2024 | |
| PHGE BiomX | Initiates: Buy | $25 | $0.54 | +4,537.36% | 1 | May 28, 2024 | |
| INAB IN8bio | Initiates: Buy | $7.5 | $0.17 | +4,426.25% | 1 | Mar 18, 2024 | |
| CING Cingulate | Downgrades: Hold | n/a | $4.08 | - | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.06 | +843.40% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.42 | - | 1 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $1.46 | +16,338.36% | 1 | Sep 6, 2022 |
iCAD, Inc.
Apr 17, 2025
Downgrades: Hold
Price Target: n/a
Current: $3.05
Upside: -
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $69.21
Upside: +51.71%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $8.48
Upside: +124.06%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $10
Current: $1.41
Upside: +609.22%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $6.34
Upside: +657.10%
MEI Pharma
Jul 23, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.91
Upside: -
Affimed
Jun 13, 2024
Maintains: Buy
Price Target: $15 → $25
Current: $0.72
Upside: +3,393.08%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $25
Current: $0.54
Upside: +4,537.36%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $7.5
Current: $0.17
Upside: +4,426.25%
Cingulate
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.08
Upside: -
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $1.06
Upside: +843.40%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.42
Upside: -
Sep 6, 2022
Initiates: Buy
Price Target: $240
Current: $1.46
Upside: +16,338.36%